Maryland Life Sciences
Maryland at BIO
Get to Know Maryland.
Maryland has its very own ecosystem of life sciences companies, making the state an impressive hub for scientific innovation. Maryland's life sciences industry not only stands out among other states, but also shines internationally. Our team, along with a delegation of Maryland companies, will represent Maryland at the BIO International Convention on June 3-6, 2024. Visit the Commerce team at Booth No. 4345 to see what Maryland offers businesses. Below, you can learn more about the leaders behind some life sciences companies that proudly call Maryland home and find their direct contact info for those interested in partnering.
The Maryland Delegation
COMPANIES ATTENDING BIO INTERNATIONAL
These companies will be attending the Maryland pavilion at the BIO International Convention. Scroll below for full company profiles.
Creates and sells innovative biocontrol solutions that tackle diseases impacting humans, plants, and the environment.
Discovering and developing innovative therapies to improve the lives of millions affected by neurological disorders like Alzheimer’s disease.
A cryotherapy company brining minimally invasive tumor treatment to traditionally underserved markets.
Improving the quality of care for patients with Chronic Obstructive Pulmonary Disease (COPD) and their providers with its innovative, device-enabled solution.
Unlocking melanin's potential to improve human life through protection, warmth, and energy.
Developing a new imaging technology that opens an entirely new domain for exploring cell biology and identifying molecular targets for drug development.
Developing the mitochondrial modulator drug discovery platform to identify clinical candidates for diseases of underlying mitochondrial dysfunction.
Providing surgical confidence in the operating room, making critical anatomy visible by providing structural and functional tissue information to operating surgeons in real-time to improve patient health.
Providing precision medicine solutions to guide patient care, initially focused on upper GI conditions such as GERD and esophageal precancer.
Protects food sources and life sustaining systems for future generations with its.novel RNA therapy to immunize and enhance trees.
A clinical-ready, pharmaceutical company developing therapies to restore nerve function.
Working to commercialize a next-generation bone fracture healing device based on its patent-pending acoustic shear wave technology.
Developing new therapies for life-threatening immuno-inflammatory diseases.
Revolutionizing cancer treatment with its AI-guided precision dosimetry, enhancing radiation therapy accuracy and patient outcomes.
Creates and sells innovative biocontrol solutions that tackle diseases impacting humans, plants, and the environment.
Discovering and developing innovative therapies to improve the lives of millions affected by neurological disorders like Alzheimer’s disease.
A cryotherapy company brining minimally invasive tumor treatment to traditionally underserved markets.
Improving the quality of care for patients with Chronic Obstructive Pulmonary Disease (COPD) and their providers with its innovative, device-enabled solution.
Unlocking melanin's potential to improve human life through protection, warmth, and energy.
Developing a new imaging technology that opens an entirely new domain for exploring cell biology and identifying molecular targets for drug development.
Developing the mitochondrial modulator drug discovery platform to identify clinical candidates for diseases of underlying mitochondrial dysfunction.
Providing surgical confidence in the operating room, making critical anatomy visible by providing structural and functional tissue information to operating surgeons in real-time to improve patient health.
Providing precision medicine solutions to guide patient care, initially focused on upper GI conditions such as GERD and esophageal precancer.
Protects food sources and life sustaining systems for future generations with its.novel RNA therapy to immunize and enhance trees.
A clinical-ready, pharmaceutical company developing therapies to restore nerve function.
Working to commercialize a next-generation bone fracture healing device based on its patent-pending acoustic shear wave technology.
Developing new therapies for life-threatening immuno-inflammatory diseases.
Revolutionizing cancer treatment with its AI-guided precision dosimetry, enhancing radiation therapy accuracy and patient outcomes.
#3
Technology and science workforce
#2
Federal obligations for R&D
2x
Federal labs than any other state
#5
Highest concentration doctoral scientists and engineers.
Auxergen Inc.
Auxergen Inc. creates and sells innovative biocontrol solutions that tackle diseases impacting humans, plants, and the environment.
The company's mission is to reduce the use of chemical pesticides in agriculture, to reduce toxic runoff and to promote watershed and environmental health. Auxergen is searching for novel applications of discoveries at the nexus of human, animal and plant diseases.
Contact:
Dr. Ting-Yi Yeh, Co-Founder & Chief Science Officer
Fzata, Inc.
Fzata is an NIH-SEED company in drug development. The company leverages its yeast platform to develop first-in-class, oral, live yeast synthetic biologic drugs. Yeast acts as a “factory” making drug on-site in the GI.
Fzata is is located at bwtech@UMBC, employing 10 FTE with four fully equipped labs and offices. Yeast platform and asset patents are granted and pending in US and PCT.
Contact:
Elizabeth Smith, Chief Business Officer
IGC Pharma, Inc.
IGC Pharma, Inc. is a small clinical stage pharmaceutical company engaged in Alzheimer's research. Their lead formulation is in a Phase 2b trial on agitation in dementia from Alzheimer's.
The company's mission is to improve the lives of millions affected by neurological disorders, providing relief to those suffering from these conditions, while advancing the understanding and treatment of women’s health needs throughout their lives.
Contact:
Ram Mukunda, CEO
Kubanda Cryotherapy Inc.
Kubanda is a cryotherapy company brining minimally invasive tumor treatment to traditionally underserved markets.
The company's beachhead market is veterinary medicine. A premium procedure that’s simpler than surgery, with cryotherapy, clinics can charge less while making more and providing higher level care.
Contact:
Bailey Surtees, CEO
LASARRUS
LASARRUS improves the quality of care for patients with Chronic Obstructive Pulmonary Disease (COPD) and their providers with its innovative technology.
The company is creating device-enabled solutions for remote monitoring of COPD that is reliable, accurate and easy to use.
Contact:
Dr. Lloyd Emokpae, CEO
MelaTech
MelaTech is an early-stage biotechnology company whose mission is to develop and mass manufacture melanin-based biomaterials for radiation shielding and energy capture applications.
The company specializes in the sustainable production of natural melanins using microorganisms for a cost-effective alternative to scarce animal and plant sources. Their melanin preparations exhibit unique physical-chemical properties and can be tailored to specific applications.
Contact:
Dr. Radamés J.B. Cordero, CEO & Co-Founder
Nanocrine, Inc.
Nanocrine is developing a new imaging technology that opens an entirely new domain for exploring cell biology and identifying molecular targets for drug development.
The company's key technology, named Nanoplasmonic Imaging, enables real-time, label-free, quantitative analysis of the extracellular environment during live-cell imaging.
Contact:
Patrick Calhoun, President & Chief Science Officer
Neuroene Therapeutics
Neuroene Therapeutics is a small biotech startup developing mitochondrial therapeutics for difficult to treat neurological diseases.
The company's objective is to develop its mitochondrial modulator drug discovery platform to identify clinical candidates for diseases of underlying mitochondrial dysfunction. Neuroene Therapeutics’ portfolio includes issued and pending patents covering hundreds of analogs aimed at the treatment of numerous disease indications and the corresponding methods.
Contact:
Dr. Sherine Chan, Co-Founder & CEO
Optosurgical, LLC.
Optosurgical, LLC is an early-stage startup that specializes in the research and development (R&D) of intraoperative imaging technologies and holds technical expertise in biomedical optics, surgical vision, and stakeholder/clinical validations.
The company's lead innovation utilizes fluorescence imaging technology to guide surgeons in thyroid and parathyroid surgery. Their solution enables head and neck surgeons to visualize parathyroid glands and assess perfusion dye-free, which leads to operational efficiencies and improved patient outcomes.
Contact:
Yoseph Kim, CEO
Previse
Previse is a gastrointestinal health company that provides precision medicine solutions to guide patient care, initially focused on upper GI conditions such as GERD and esophageal precancer.
The company is actively working to get patients and healthcare providers the answers they need sooner by understanding and unlocking the power of biomarkers on cancer development and severity. Previse's early-detection system combines a simple routine test given as part of routine care with our patented DNA biomarkers that accurately test for disease.
Contact:
Daniel Lunz, CEO
Silvec Biologics Inc.
Silvec Biologics Inc. is an agricultural biotechnology company that is developing RNA therapies for trees.
The company's products are based on a novel type of RNA which can be engineered to target almost any virus, bacteria, or fungus without altering the host’s genome. A single application of the proprietary RNA therapy can provide lifetime protection for a tree, vine, or bush against many diseases, eliminating much of the need for genetic modification.
Contact:
Rafael Simon, CEO
Solaxa Inc.
Solaxa Inc. is clinical-ready, pharmaceutical company developing therapies for rare neurodegenerative disease and acute nerve injuries.
The company is pursuing both novel and reformulated drugs to restore nerve function by targeting ion channels. Aminopyridines are a potent class of ion channel blockers where Solaxa’s newly discovered and patented mechanisms of action offer treatment advancements in both chronic and acute use.
Contact:
Christian Walker, CEO & Founder
Sonogen Medical, Inc.
Sonogen Medical, Inc. is a medical technology company, working to commercialize a next-generation bone fracture healing device based on its patent-pending acoustic shear wave technology.
Sonogen’s device delivers a therapeutic ultrasound signal that has been proven to heal 30% faster than the current standard of care. The device is also specifically designed to maximize patient compliance through fracture healing monitoring and usage feedback, and is fully mobile app and telehealth enabled.
Contact:
Jason Winder, CEO
Veralox Therapeutics
.Veralox Therapeutics is a startup biotech focused on developing treatment for serious immune mediated diseases.
Based on an understanding of the 12-LOX pathway and molecular mechanisms of HIT, T1D and emerging discoveries in additional immuno-inflammatory diseases, Veralox Therapeutics' efforts are leading to novel treatment paradigms and better outcomes for patients.
Contact:
Lisa Beck, Chief Business Officer
WearableDose
WearableDose revolutionizes cancer treatment with its AI-guided precision dosimetry, enhancing radiation therapy accuracy and patient outcomes.
The company is committed to elevating safety standards in various industries through early detection technologies. WearableDose aims to protect workers who operate in radiation-intensive settings, ensuring their well-being and peace of mind.
Contact:
John Sanwo, Founder
